Barcelona, Spain

Barcelona 08195

0 studies enrolling now · 2 studies all time

What they study most

Advanced Solid Tumors, Diabetic Macular Edema (DME), Lymphoma

Studies at this site

• A Study to Evaluate the Efficacy and Safety of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME — Running, not enrolling
• Pre-Screening Study to Identify MTAP Loss in Advanced Solid Tumors or Lymphoma — Completed